Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-25-002339
Filing Date
2025-04-08
Accepted
2025-04-08 20:23:23
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 12551
2 d11778051_ex99-a.htm EX-99 7882
3 d11778051_ex99-b.htm EX-99 729
  Complete submission text file 0000919574-25-002339.txt   22978
Mailing Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656
Business Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656 949-521-7822
RxSight, Inc. (Subject) CIK: 0001111485 (see all company filings)

EIN.: 943268801 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92778 | Film No.: 25823347
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)

Mailing Address 3480 MAIN HIGHWAY SUITE 204 MIAMI FL 33133
Business Address 3480 MAIN HIGHWAY SUITE 204 MIAMI FL 33133 415-378-0636
Divisadero Street Capital Management, LP (Filed by) CIK: 0001901865 (see all company filings)

EIN.: 872846246 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G